Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$0.55 - $0.82 $9,449 - $14,087
17,180 Added 8.75%
213,600 $152,000
Q1 2023

May 12, 2023

SELL
$0.65 - $1.37 $88,760 - $187,078
-136,554 Reduced 41.01%
196,420 $146,000
Q4 2022

Feb 13, 2023

SELL
$0.6 - $1.41 $88,840 - $208,774
-148,067 Reduced 30.78%
332,974 $242,000
Q3 2022

Nov 14, 2022

BUY
$0.94 - $2.56 $153,859 - $419,020
163,680 Added 51.58%
481,041 $467,000
Q2 2022

Aug 12, 2022

BUY
$1.78 - $5.02 $188,966 - $532,928
106,161 Added 50.27%
317,361 $606,000
Q1 2022

May 13, 2022

BUY
$3.54 - $8.08 $564,984 - $1.29 Million
159,600 Added 309.3%
211,200 $1.05 Million
Q4 2021

Feb 11, 2022

SELL
$5.69 - $7.83 $1.99 Million - $2.73 Million
-349,188 Reduced 87.13%
51,600 $390,000
Q3 2021

Nov 12, 2021

BUY
$7.88 - $14.0 $3.16 Million - $5.61 Million
400,788 New
400,788 $3.17 Million
Q4 2020

Feb 10, 2021

SELL
$12.83 - $17.84 $1.41 Million - $1.96 Million
-109,900 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$11.01 - $18.52 $1,101 - $1,852
-100 Reduced 0.09%
109,900 $1.87 Million
Q2 2020

Aug 13, 2020

SELL
$11.11 - $24.72 $40,029 - $89,066
-3,603 Reduced 3.17%
110,000 $1.83 Million
Q1 2020

May 14, 2020

BUY
$10.74 - $16.32 $18,290 - $27,792
1,703 Added 1.52%
113,603 $1.32 Million
Q4 2019

Feb 13, 2020

BUY
$12.94 - $20.58 $1.09 Million - $1.74 Million
84,500 Added 308.39%
111,900 $1.66 Million
Q3 2019

Nov 13, 2019

BUY
$10.93 - $17.47 $299,482 - $478,677
27,400 New
27,400 $374,000

Others Institutions Holding HARP

About Harpoon Therapeutics, Inc.


  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.